Earnings Call Intelligence Subscribe
Home › Call Sheets › ECL › Q3'26
Call sheet · Q3'26

Ecolab (ECL)

Q3'26 earnings call · held October 27, 2026 · compared with the Q2'26 call · management-credibility review
7/12
Disclosure score
5 medium, 3 low flags
Financial quality
Bottom line
The market will cheer 7% organic growth and a 19.6% organic OI margin, but the sleeper story is that Ecolab just reversed its capacity posture because capacity, not demand, is now the binding constraint in Global High Tech, while the pest intelligence device count has been frozen near 800,000 for two straight quarters against a slipping 'by year-end' target that's quietly become 'a year or two'. The obvious headline, 63% GHT growth, is itself being walked back in real time by management ('63% is not going to be the steady state growth that we're planning'), and the newly admitted institutional volume decline paired with Beck's 'I'm not satisfied with our results' suggests a large piece of the portfolio is weaker than last quarter's 'darn good place' framing implied. My view changes if the November Investor Day finally delivers a real $/MW unit economics number for GHT instead of the same '3-5x directional' hedge repeated for two quarters running, or if Q4 shows the pest device count actually move off 800,000.

The 30-second version

  • The pest intelligence device count hasn't moved in three months, and the 1-million-device target just quietly slipped
  • Global High Tech's 63% growth is the headline, but management just reversed its capacity strategy to chase it
  • Institutional business: management admitted the quiet part out loud

What changed this quarter

MetricQ2'26Q3'26Change
Organic Sales Growth5% (Q2 2026)7% (Q3 2026)+200bps acceleration
Organic OI Margin19% guided for H2 202619.6% actualBeat guide by ~60bps
Organic OI GrowthNot broken out as a standalone metric; Q2 commentary centered on 11% adjusted EPS growth11%New standalone disclosure, strong print
Pro Forma Sales Growth (incl. Cool IT/Avivo)Approximately 7% pro forma (Q2)High single digits pro formaDenominator game: blends organic growth with full-period M&A
Global High Tech Organic Growth29%63%More than doubled; management says not repeatable
Cool IT GrowthMore than 100% YTD pre-acquisition sales growth (Q2 2026)More than doubling salesStill torrid but decelerating as base grows
Life Sciences Organic Growth15%17%+200bps
Life Sciences Margin Guide (next qtr)High teens guided for Q3Mid-to-high teens guided for Q4, after Q3 outperformance tied to lapping a 2025 maintenance periodOne-time comparison tailwind inflated Q3, reverting
Ecolab Digital Growth27%34%+700bps acceleration
Pest Elimination Growth7%8%+100bps, in-range

Accountability tracked

6 new promises made6 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full ECL Q3'26 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.